fluoropaclitaxel
Small moleculeexperimentalImaging agent
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2005 (NCT00572598)
Timeline
2000s
- Jan 1, 2005
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 18-fluorine
Oral
No
Parenteral
No
Topical
No
Also known as
- f-18 paclitaxel
- fluoropaclitaxel
- fluoropaclitaxel
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01086696 | Early Phase 1 (Phase 1) | Mar 9, 2010 | National Cancer Institute (NCI) |
| NCT00572598 | Early Phase 1 (Phase 1) | May 1, 2005 | Virginia Commonwealth University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Cancer Institute (NCI) | Government | 1 | 1 | 1 | 2010 |
| Virginia Commonwealth University | Academic/Hospital | 1 | 1 | 1 | 2005 |
2 organizations
Page 1 / 1